Massachusetts General HospitalBoston, MA
Disclosures:
SS 16 - Lung 3: Clinical Trials of Chemoradioimmunotherapy and Risk Adapted Radiotherapy for Advanced Lung Cancer
Monday, September 30, 202410:45 AM – 12:00 PM ET
261 - A Phase II Trial of Stereotactic Body Radiotherapy (SBRT) in Patients with Stage IV Oncogene-Driven Non-Small Cell Lung Cancer (NSCLC)
Tuesday, October 1, 20248:40 AM – 8:50 AM ET